Future studies are warranted to fill these voids and to determine, for instance, whether TBX2 subfamily methylation levels differ by mutational status of key driver genes—though it is noteworthy to highlight what we have shown here, that methylation of these genes is a common event in NSCLC cell lines with likely disparate mutated drivers. This evidence concerns the gene TBX2 and non-small cell lung carcinoma.